https://www.statnews.com/2026/04/16/travere-therapeutics-kidney-disease-fda-approval/
Travere drug doesn’t improve kidney function. The FDA still approved it | STAT
The agency has taken heat for not showing enough regulatory flexibility. In the case of Filspari, it showed too much.
kidney functiondrugimprovefdastill